https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2002-05-01 / Br. J. Haematol. 2002 May;117(2):297-305
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2002-05-01 / Br. J. Haematol. 2002 May;117(2):297-3052002-05-01 00:00:002019-02-15 08:51:10Optimizing dendritic cell-based immunotherapy in multiple myeloma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2002-04-01 / Blood 2002 Apr;99(7):2512-7
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2002-04-01 / Blood 2002 Apr;99(7):2512-72002-04-01 00:00:002019-02-15 08:51:11Immunization against murine multiple myeloma with fusions of dendritic and plasmacytoma cells is potentiated by interleukin 12
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2002-02-01 / Bone Marrow Transplant. 2002 Feb;29(3):213-21
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2002-02-01 / Bone Marrow Transplant. 2002 Feb;29(3):213-212002-02-01 00:00:002019-02-15 08:51:12Idiotype protein-pulsed dendritic cells produce strong anti-myeloma effects after syngeneic stem cell transplantation in mice
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2002-01-01 / Med. Oncol. 2002;19(4):213-8
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2002-01-01 / Med. Oncol. 2002;19(4):213-82002-01-01 00:00:002019-02-15 08:51:08Dendritic cell vaccines in the treatment of multiple myeloma: advances and limitations
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2001-07-01 / Semin. Hematol. 2001 Jul;38(3):260-7
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2001-07-01 / Semin. Hematol. 2001 Jul;38(3):260-72001-07-01 00:00:002019-02-15 08:51:13Immunotherapy of multiple myeloma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2001-01-01 / Exp. Hematol. 2001 Jan;29(1):85-92
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2001-01-01 / Exp. Hematol. 2001 Jan;29(1):85-922001-01-01 00:00:002019-02-15 08:51:14Dendritic cells derived from multiple myeloma patients efficiently internalize different classes of myeloma protein
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2000-03-01 / Br. J. Haematol. 2000 Mar;108(4):805-16
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2000-03-01 / Br. J. Haematol. 2000 Mar;108(4):805-162000-03-01 00:00:002019-02-15 08:51:14Vaccination of multiple myeloma patients with idiotype-pulsed dendritic cells: immunological and clinical aspects
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2000-02-01 / Med. Oncol. 2000 Feb;17(1):2-15
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2000-02-01 / Med. Oncol. 2000 Feb;17(1):2-152000-02-01 00:00:002019-02-15 08:51:15Dendritic cell biology and the application of dendritic cells to immunotherapy of multiple myeloma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
1999-12-01 / Br. J. Haematol. 1999 Dec;107(3):648-55
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
1999-12-01 / Br. J. Haematol. 1999 Dec;107(3):648-551999-12-01 00:00:002019-02-15 08:51:16Generation of anti-idiotype immune responses following vaccination with idiotype-protein pulsed dendritic cells in myeloma
